Literature DB >> 21986840

Downregulation of MEIS1 impairs long-term expansion of CD34+ NPM1-mutated acute myeloid leukemia cells.

C M Woolthuis, L Han, R N Verkaik-Schakel, D van Gosliga, P M Kluin, E Vellenga, J J Schuringa, G Huls.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21986840     DOI： 10.1038/leu.2011.277

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.

Authors:  Carolien M Woolthuis; André B Mulder; Rikst Nynke Verkaik-Schakel; Stefano Rosati; Arjan Diepstra; Eva van den Berg; Jan Jacob Schuringa; Edo Vellenga; Philip M Kluin; Gerwin Huls
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

2.  Analyse multiple disease subtypes and build associated gene networks using genome-wide expression profiles.

Authors:  Sara Aibar; Celia Fontanillo; Conrad Droste; Beatriz Roson-Burgo; Francisco J Campos-Laborie; Jesus M Hernandez-Rivas; Javier De Las Rivas
Journal:  BMC Genomics       Date:  2015-05-26       Impact factor: 3.969

3.  Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1;Cohesin mutated AML.

Authors:  Alison E Meyer; Cary Stelloh; Kirthi Pulakanti; Robert Burns; Joseph B Fisher; Katelyn E Heimbruch; Sergey Tarima; Quinlan Furumo; John Brennan; Yongwei Zheng; Aaron D Viny; George S Vassiliou; Sridhar Rao
Journal:  Leukemia       Date:  2022-07-01       Impact factor: 12.883

4.  A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site.

Authors:  Sylvia T Nürnberg; Augusto Rendon; Peter A Smethurst; Dirk S Paul; Katrin Voss; Jonathan N Thon; Heather Lloyd-Jones; Jennifer G Sambrook; Marloes R Tijssen; Joseph E Italiano; Panos Deloukas; Berthold Gottgens; Nicole Soranzo; Willem H Ouwehand
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

5.  Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia.

Authors:  Szymon Klossowski; Hongzhi Miao; Katarzyna Kempinska; Tao Wu; Trupta Purohit; EunGi Kim; Brian M Linhares; Dong Chen; Gloria Jih; Eric Perkey; Huang Huang; Miao He; Bo Wen; Yi Wang; Ke Yu; Stanley Chun-Wei Lee; Gwenn Danet-Desnoyers; Winifred Trotman; Malathi Kandarpa; Anitria Cotton; Omar Abdel-Wahab; Hongwei Lei; Yali Dou; Monica Guzman; Luke Peterson; Tanja Gruber; Sarah Choi; Duxin Sun; Pingda Ren; Lian-Sheng Li; Yi Liu; Francis Burrows; Ivan Maillard; Tomasz Cierpicki; Jolanta Grembecka
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

6.  Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation.

Authors:  Pallavi Sontakke; Katarzyna M Koczula; Jennifer Jaques; Albertus T J Wierenga; Annet Z Brouwers-Vos; Maurien Pruis; Ulrich L Günther; Edo Vellenga; Jan Jacob Schuringa
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

7.  Regulation of MEIS1 by distal enhancer elements in acute leukemia.

Authors:  Q F Wang; Y J Li; J F Dong; B Li; J J Kaberlein; L Zhang; F E Arimura; R T Luo; J Ni; F He; J Wu; R Mattison; J Zhou; C Z Wang; S Prabhakar; M A Nobrega; M J Thirman
Journal:  Leukemia       Date:  2013-09-11       Impact factor: 11.528

Review 8.  A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML.

Authors:  Katelyn E Heimbruch; Alison E Meyer; Puja Agrawal; Aaron D Viny; Sridhar Rao
Journal:  Neoplasia       Date:  2021-02-20       Impact factor: 5.715
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.